Articles Vol. 63 No. 4 (2022) 08/08/2022

LDL CHOLESTEROL ACHIEVEMENT IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS ACCORDING TO EUROPEAN SOCIETY OF CARDIOLOGY 2019 GUIDELINE

Nguyen Van Si1,2, Tran Xuan Truong3,4, Vo Thanh Duy1,2, Nguyen Thi Thu Thuy1,2, Pham Truong My Dung5,6, Do Minh Thuc7,8
1 University of Medicine and Pharmacy at Ho Chi Minh city
2 Đại học Y Dược thành phố Hồ Chí Minh
3 Pham Ngoc Thach University of Medicine
4 Đại học Y khoa Phạm Ngọc Thạch
5 Nhan Dan Gia Dinh Hospital
6 Bệnh viện Nhân dân Gia Định
7 Giong Rieng Hospital
8 Bệnh viện Giồng Riềng
Corresponding author: si.nguyen@ump.edu.vn
DOI: 10.52163/yhc.v63i4.368
21 Views
0 Downloads
Keywords
Dyslipidemia, LDL-C, high and very high cardiovascular risk, statin.
Abstract

Objective: To evaluate the rate of target achievement of LDL-C in high and very high cardiovascular
risk patients. Methods: A retrospective study of cardiology outpatient database in Nhan dan Gia
Dinh Hospital from 2020 January to 2021 January was conducted. Prescriptions before and after lipid
investigation were collected to consider the statin prescription behavior. Results: LDL-C targets
were achieved in 29.17% and 8.24% of high risk and very high risk patients, respectively. A majority
(83.46%) were on intermediate intensity and 16.54% were on high intensity statin treatment. Statin
dose increment rate was 23.21% in unachieved LDL-C patients. Conclusion: LDL-C achievement
rates were modest in high and very high cardiovascular risk patients while the statin prescription was
not adequate.

References
[1]
Mach F, “2019 ESC/EAS Guidelines for Google Scholar
[2]
the management of dyslipidaemias: lipid Google Scholar
[3]
modification to reduce cardiovascular riskThe Google Scholar
[4]
Task Force for the management of dyslipidaemias Google Scholar
[5]
of the European Society of Cardiology (ESC) and Google Scholar
[6]
European Atherosclerosis Society (EAS),” Eur. Google Scholar
[7]
Heart J., vol. 41, no. 1, pp. 111–188, Jan. 2020. Google Scholar
[8]
Bruckert E, “Proportion of High-Risk/Very Google Scholar
[9]
High-Risk Patients in Europe with LowDensity Lipoprotein Cholesterol at Target Google Scholar
[10]
According to European Guidelines: A Google Scholar
[11]
Systematic Review,” Adv. Ther., vol. 37, no. Google Scholar
[12]
, pp. 1724–1736, May 2020. Google Scholar
[13]
Petrov I, “Clinical Management of High and Google Scholar
[14]
Very High Risk Patients with Hyperlipidaemia Google Scholar
[15]
in Central and Eastern Europe: An Observational Google Scholar
[16]
Study,” Adv. Ther., vol. 36, no. 3, p. 608, Mar. Google Scholar
[17]
, doi: 10.1007/S12325-019-0879-1. Google Scholar
[18]
Krittayaphong R, “The rate of patients at high Google Scholar
[19]
risk for cardiovascular disease with an optimal Google Scholar
[20]
low-density cholesterol level: a multicenter study Google Scholar
[21]
from Thailand,” J. Geriatr. Cardiol., vol. 16, no. Google Scholar
[22]
, p. 344, 2019. Google Scholar
[23]
Vrablik M, “Lipid-lowering therapy use in Google Scholar
[24]
primary and secondary care in Central and Google Scholar
[25]
Eastern Europe: DA VINCI observational study,” Google Scholar
[26]
Atherosclerosis, vol. 334, pp. 66–75, Oct. 2021. Google Scholar
[27]
Naito R, Miyauchi K, Daida H, “Racial Google Scholar
[28]
Differences in the Cholesterol-Lowering Effect Google Scholar
[29]
of Statin,” J. Atheroscler. Thromb., vol. 24, no. Google Scholar
[30]
, p. 19, 2017. Google Scholar
[31]
Newman CB, “Statin Safety and Associated Google Scholar
[32]
Adverse Events: A Scientific Statement From Google Scholar
[33]
the American Heart Association,” Arterioscler. Google Scholar
[34]
Thromb. Vasc. Biol., vol. 39, no. 2, pp. E38–E81, Google Scholar
[35]
Feb. 2019. Google Scholar
[36]
Goldberg KC, “Overcoming inertia: improvement Google Scholar
[37]
in achieving target low-density lipoprotein Google Scholar
[38]
cholesterol,” Am J Manag Care., vol. 13, no. 9, Google Scholar
[39]
p. 540-4, 2007. Google Scholar